Why We Need Open Source Pharma
BY TOMASZ SABLINSKI
Tomasz Sablinski is the CEO of Transparency Life Sciences. He is @TSablinski on Twitter. |
Other essays in this series: James Kassaga Arinaitwe, Global Health Corps & Aspen Institute Fellow / Kampala Manica Balasegaram, Exec. Director, Access Campaign, Médecins Sans Frontières / Geneva Polly J. Price, Emory University law professor / Atlanta John Wilbanks, Chief Commons Officer, Sage Bionetworks / Washington, D.C. Dimitrios Tzalis, Founder & CEO, Taros Chemicals GmbH & Co. KG. / Dortmund T.V. Mohandas Pai, Chairman, Manipal Global Education Services / Bangalore Els Torreele, Director, Access to Essential Medicines Initiative, Open Society Foundations / NYC Zakir Thomas, Open innovation expert & former Project Director of OSDD / Delhi Matthew Todd, Founder of Open Source Malaria / Sydney & Cambridge |